AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, *antiOx↑, *Ca+2↓, *BioAv↓, *BioAv↑, *BioAv↑, *angioG↑, *MAPK↓, *AMPK↓, *NF-kB↓, VEGF↓, PI3K↓, Akt↓, MMP2↓, Bcl-2↓, ERK↓,
*5LO↓, *TNF-α↓, *MMP3↓, *COX1↓, *COX2↓, *PGE2↓, *Th2↑, *Catalase↑, *SOD↑, *NO↑, *PGE2↑, *IL1β↓, *IL6↓, *Th1 response↓, *Th2↑, *iNOS↓, *NO↓, *p‑JNK↓, *p38↓, GutMicro↑, p‑Akt↓, GSK‐3β↓, cycD1/CCND1↓, Akt↓, STAT3↓, CSCs↓, AR↓, P21↑, DR5↑, CHOP↑, Casp3↑, Casp8↑, cl‑PARP↑, DNAdam↑, p‑RB1↓, FOXM1↓, TOP2↓, CDC25↓, p‑CDK1↓, p‑ERK↓, MMP9↓, VEGF↓, angioG↓, ROS↑, Cyt‑c↑, AIF↑, Diablo↑, survivin↓, ICAD↓, ChemoSen↑, SOX9↓, ER Stress↑, GRP78/BiP↑, cal2↓, AMPK↓, mTOR↓, ROS↓,
| - |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
TumCP↓, TumCG↓, TumCCA↑, AMPK↓, NF-kB↓, β-catenin/ZEB1↓, CREB↓, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓,
*Akt↑, *AMPK↓, *TGF-β↓, eff↑, *BioEnh↑, *ATP↑, *PGC-1α↑, *p‑mTOR↑, *SMAD3↓,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
TumCMig↓, TumCI↓, MDA↑, ROS↑, BAX↑, Casp3↑, Bcl-2↓, SREBP1↓, FASN↓, AMPK↓, p‑AMPK↑, p‑P53↑, p‑TSC2↑, p‑Akt↓, p‑mTOR↓, p‑S6K↓, p‑4E-BP1↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
*MDA↓, *H2O2↓, *Catalase↑, *SOD↑, *GSTs↑, *GSH↑, *NRF2↓, *ATG3↓, *AMPK↓, *ROS↓,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
MDA↑, 1, ROS↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, CDC25↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↓, 4, p‑AMPK↑, 1, CREB↓, 1, FASN↓, 1, GlucoseCon↓, 1, lactateProd↓, 1, p‑S6K↓, 1, SREBP1↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 3, p‑Akt↓, 2, BAX↑, 1, Bcl-2↓, 3, Bcl-xL↓, 1, Casp1↓, 1, Casp3↑, 3, Casp8↑, 1, Cyt‑c↑, 1, Diablo↑, 1, DR5↑, 1, ICAD↓, 1, MDM2↓, 1, survivin↓, 1,
Kinase & Signal Transduction ⓘ
SOX9↓, 1, p‑TSC2↑, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1, HSP27↓, 1,
Autophagy & Lysosomes ⓘ
BNIP3↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, p‑P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
p‑CDK1↓, 1, CDK2↓, 1, CDK4↓, 2, cycD1/CCND1↓, 3, cycE/CCNE↓, 1, P21↑, 1, p‑RB1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
p‑4E-BP1↓, 1, CSCs↓, 1, EMT↓, 1, ERK↓, 1, p‑ERK↓, 1, FOXM1↓, 2, GSK‐3β↓, 1, HDAC2↓, 1, mTOR↓, 2, p‑mTOR↓, 1, PI3K↓, 2, STAT3↓, 2, TOP2↓, 1, TumCG↓, 2,
Migration ⓘ
cal2↓, 1, E-cadherin↑, 1, GIT1↓, 1, MARK4↓, 1, MMP2↓, 2, MMP9↓, 2, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1, Zeb1↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 3,
Immune & Inflammatory Signaling ⓘ
ASC↑, 1, ICAM-1↓, 1, IL6↑, 1, NF-kB↓, 1, p‑p65↓, 1, TLR4↓, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↑, 1,
Clinical Biomarkers ⓘ
AR↓, 1, FOXM1↓, 2, GutMicro↑, 1, IL6↑, 1,
Total Targets: 89
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 2, GSH↑, 1, GSTs↑, 1, H2O2↓, 1, MDA↓, 1, NRF2↓, 1, ROS↓, 2, SOD↑, 2,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, MMP↑, 1, PGC-1α↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↓, 3,
Cell Death ⓘ
Akt↑, 1, iNOS↓, 1, p‑JNK↓, 1, MAPK↓, 1, p38↓, 1,
Autophagy & Lysosomes ⓘ
ATG3↓, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑mTOR↑, 1,
Migration ⓘ
5LO↓, 1, Ca+2↓, 1, MMP3↓, 1, SMAD3↓, 1, TGF-β↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, NO↓, 1, NO↑, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 2, HMGB1↓, 1, IL1β↓, 2, IL6↓, 2, Inflam↓, 2, NF-kB↓, 2, PGE2↓, 2, PGE2↑, 1, Th1 response↓, 1, Th2↑, 2, TNF-α↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, BioEnh↑, 1,
Clinical Biomarkers ⓘ
IL6↓, 2,
Functional Outcomes ⓘ
memory↑, 1, neuroP↑, 1,
Total Targets: 47
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:9 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page